Herpes Zoster
Conditions
Interventions
Low dose group:Valaciclovir 300mg, twice daily for 7-10 days
Medium dose group:Valaciclovir 600mg, twice daily for 7-10 days
High dose group:Valaciclovir 900mg, three times a day for 7-10 days
Sponsors
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 18-65 years old, acute onset, patient's course of illness <= 5 days.
Exclusion criteria
Exclusion criteria: Who are allergic to valacyclovir and its derivatives; those who have severe immune function or need to take immunosuppressants for a long time; those who have impaired liver and kidney function and other important organ functions; patients with diabetes; Women during pregnancy and lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin rash evaluation; | — |
Countries
China
Contacts
Public ContactHongliang Yao
Department of Dermatology, the Fourth Affiliated Hospital, Zhejiang University School of Medicine
Outcome results
None listed